EP3473642A2 — Compositions and methods of using islet neogenesis peptides and analogs thereof
Assigned to Shenzhen Hightide Biopharmaceutical Ltd · Expires 2019-04-24 · 7y expired
What this patent protects
Provided herein are peptides and analogs of INGAP and HIP peptides and modifications thereof. Also provided herein are said peptides, analogs or modifications thereof for use in methods of treating various diseases and conditions including impaired pancreatic function and metabol…
USPTO Abstract
Provided herein are peptides and analogs of INGAP and HIP peptides and modifications thereof. Also provided herein are said peptides, analogs or modifications thereof for use in methods of treating various diseases and conditions including impaired pancreatic function and metabolic diseases, for example, diabetes (types 1 and 2). The uses also include islets induction, expansion and proliferation for transplantation, promoting neuroprotection or nerve regeneration, promoting liver regeneration or inhibition inflammation.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.